Skip to main content
. 2022 Jan 7;16(5):706–715. doi: 10.5009/gnl210293

Table 2.

Differences between Intestinal-Type and Diffuse-Type Gastric Cancer According to Reproductive Factors in Total, Postmenopausal and Premenopausal Females

Variable Total females Postmenopausal females Premenopausal females
Diffuse (n=274) Intestinal (n=150) p-value Diffuse (n=172) Intestinal (n=126) p-value Diffuse (n=102) Intestinal (n=24) p-value
Age, yr 53.98±11.55 63.02±10.33 <0.001* 60.69±8.03 65.99±8.05 <0.001* 42.68±6.80 47.41±6.06 0.002*
<40 31 (11.3) 4 (2.7) <0.001* 0 (0.0) 0 (0.0) <0.001* 31 (30.4) 4 (16.7) 0.161
40–49 62 (22.6) 14 (9.3) 9 (5.1) 2 (1.5) 53 (52.0) 12 (50.0)
50–59 90 (32.8) 31 (20.7) 72 (41.9) 23 (18.3) 18 (17.6) 8 (33.3)
60–69 67 (24.5) 54 (36.0) 67 (39.0) 54 (42.9) 0 0
≥70 24 (8.8) 47 (31.3) 24 (14.0) 47 (37.3) 0 0
Smoking
Never 235 (85.8) 132 (88.0) 0.519 154 (89.5) 112 (88.9) 0.859 81 (79.4) 20 (83.3) 0.665
Ex/current smoker 39 (14.2) 18 (12.0) 18 (10.5) 14 (11.1) 21 (20.6) 4 (16.7)
Drinking
No 168 (61.3) 104 (69.3) 0.100 119 (69.2) 94 (74.6) 0.306 49 (48.0) 10 (41.7) 0.573
Yes 106 (38.7) 46 (30.7) 53 (30.8) 32 (25.4) 53 (52.0) 14 (58.3)
Body mass index, kg/m2
<25 203 (80.2) 102 (77.3) 0.496 123 (75.5) 86 (76.8) 0.800 80 (88.9) 16 (80.0) 0.281
≥25 50 (19.8) 30 (22.7) 40 (24.5) 26 (23.2) 10 (11.1) 4 (20.0)
Helicobacter pylori infection
Negative 116 (67.1) 78 (72.2) 0.362 45 (38.1) 25 (26.6) 0.076 12 (21.8) 5 (35.7) 0.309
Positive 57 (32.9) 30 (27.8) 73 (61.9) 69 (73.4) 43 (78.2) 9 (64.3)
Age at menarche, yr 15.25±1.80 15.81±1.89 0.003* 15.63±1.75 16.07±1.82 0.034* 14.62±1.71 14.46±1.61 0.679
<14 44 (16.1) 13 (8.7) 0.033* 19 (11.0) 6 (4.8) 0.053 25 (24.5) 7 (29.2) 0.637
≥14 230 (83.9) 137 (91.3) 153 (89.0) 120 (95.2) 77 (75.5) 17 (70.8)
Fertility duration, year 30.25±6.80 31.89±5.70 0.008* 50.26±6.01 50.83±5.39 0.399 26.56±5.79 31.04±5.40 0.001*
<30 103 (37.6) 48 (32.0) 0.250 35 (20.3) 38 (30.2) 0.052 68 (66.7) 10 (41.7) 0.023*
≥30 171 (62.4) 102 (68.0) 137 (79.7) 88 (69.8) 34 (33.3) 14 (58.3)
No. of live births
0 31 (11.3) 5 (3.3) <0.001* 11 (6.4) 4 (3.2) <0.001* 20 (19.6) 1 (4.2) 0.139
1 35 (12.8) 20 (13.3) 13 (7.6) 17 (13.5) 22 (21.6) 3 (12.5)
2 157 (57.3) 60 (40.0) 102 (59.3) 42 (33.3) 55 (53.9) 18 (75.0)
≥3 51 (18.6) 65 (43.3) 46 (26.7) 63 (50.0) 5 (4.9) 2 (8.3)
Breast feeding
Never & <6 mo 119 (44.6) 38 (26.8) <0.001* 59 (35.5) 25 (21.2) 0.009* 60 (59.4) 13 (54.2) 0.640
≥6 mo 148 (55.4) 104 (73.2) 107 (64.5) 93 (78.8) 41 (40.6) 11 (45.8)
Use of contraceptives
No 143 (71.5) 80 (70.8) 0.895 89 (73.6) 64 (68.8) 0.447 54 (68.4) 16 (80.0) 0.307
Yes 57 (28.5) 33 (29.2) 32 (26.4) 29 (31.2) 25 (31.6) 4 (20.0)
<1 yr 46 (80.7) 24 (72.7) 0.417 24 (75.0) 20 (69.0) 0.640 22 (88.0) 4 (100.0) 1.000
≥1 yr 11 (19.3) 9 (27.3) 8 (25.0) 9 (31.0) 3 (12.0) 0
Hysterectomy/oophorectomy status
No hysterectomy/oophorectomy 236 (86.1) 128 (85.3) 0.130 144 (83.7) 105 (83.3) 0.535 92 (90.2) 23 (95.8) 0.330
Hysterectomy with no ovary removed 10 (3.6) 12 (8.0) 9 (5.2) 11 (8.7) 1 (1.0) 1 (4.2)
Oophorectomy without hysterectomy 16 (5.8) 4 (2.7) 9 (5.2) 4 (3.2) 7 (6.9) 0
Hysterectomy + ovaries removed
(number unknown)
12 (4.4) 6 (4.0) 10 (5.8) 6 (4.8) 2 (1.9) 0
Hormone replacement therapy
Never & past <1 yr 149 (89.8) 104 (87.4) 0.533
Past ≥1 yr & current 17 (10.2) 15 (12.6)
Years since menopause
<10 yr 87 (50.6) 38 (30.2) <0.001*
10–20 yr 57 (33.1) 45 (35.7)
≥20 yr 28 (16.3) 43 (34.1)
Menopausal status
Premenopausal 102 (37.2) 24 (16.0) <0.001*
<10 yr after menopause 87 (31.8) 38 (25.3)
10–20 yr after menopause 57 (20.8) 45 (30.0)
≥20 yr after menopause 28 (10.2) 43 (28.7)
Tumor location
Lower 101 (37.0) 84 (57.1) <0.001*
Middle 142 (52.0) 38 (25.9)
Upper 30 (11.0) 25 (17.0)
Tumor number
Single 269 (96.4) 146 (97.3) 0.358
Multiple 8 (2.9) 4 (2.7)
Tumor size, cm 4.14±5.62 4.59±5.68 0.435

Data are presented as the mean±SD or number (%). H. pylori infection status was evaluated in a small portion of gastric cancer patients.

*Statistically significant, p<0.05; Some data were missing.